{
  "ticker": "NAN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966471",
  "id": "02966471",
  "pages": 1,
  "price_sensitive": true,
  "date": "20250707",
  "time": "0825",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250707/pdf/06ljdx9hm6bf5s.pdf",
  "summary": "**Product Launch Announcement (Key Points):**  \n- Launch of **trophon3**, a next-gen Ultrasound HLD device with **40% faster cycle time**, advanced digital integration, and expanded traceability.  \n- **trophon2 Plus** software upgrade introduced for existing customers, offering key features of trophon3.  \n- Initial rollout in **Europe, UK, Australia, NZ**; **US FDA submission pending**.  \n- Potential to **strengthen market leadership** and drive upgrades from older trophon models.  \n\n*No material financial or capital markets impact disclosed.*",
  "usage": {
    "prompt_tokens": 871,
    "completion_tokens": 121,
    "total_tokens": 992,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-06T22:33:15.262759"
}